Literature DB >> 17457835

Prospective direct comparison study of fractional resurfacing using different fluences and densities for skin rejuvenation in Asians.

Taro Kono1, Henry H Chan, William Frederick Groff, Dieter Manstein, Hiroyuki Sakurai, Masaki Takeuchi, Takashi Yamaki, Kazutaka Soejima, Motohiro Nozaki.   

Abstract

BACKGROUND AND
OBJECTIVE: Fractional resurfacing is a new concept of cutaneous remodeling whereby laser-induced zones of microthermal injury are surrounded by normal untreated tissue. The aim of this study is to compare the efficacy and complications of Fraxel laser treatment when using different fluences and density settings. STUDY DESIGN/
MATERIALS AND METHODS: Thirty female Asian patients were enrolled in the study. Group 1 (n = 10); half of the face was treated with eight passes at 125 MTZ/cm2 at an energy setting of 8 mJ. The other half of the face was treated with eight passes at 250 MTZ/cm2 at an energy setting of 8 mJ. Group 2 (n = 10); half of the face was treated with eight passes at 125 MTZ/cm2 at an energy setting of 8 mJ. The other half of the face was treated with eight passes at 125 MTZ/cm2 at an energy setting of 16 mJ. Group 3 (n = 10); half of the face was treated with eight passes at 125 MTZ/cm2 at an energy setting of 16 mJ. The other half of the face was treated with eight passes at 250 MTZ/cm2 at an energy setting of 8 mJ. Ice pack cooling was used during and after laser treatment. The patients were evaluated for clinical efficacy and treatment-related side effects.
RESULTS: Pain, erythema, and swelling were observed to be significantly more evident or persisted longer in patients treated with higher densities and fluences (P<0.01). Patient satisfaction is significantly greater in patients treated with higher fluences (P<0.05), but not in patients treated with higher densities. Hyperpigmentation was observed in two patients.
CONCLUSION: Increased density was more likely to produce swelling, redness, and hyperpigmentation when compared to increased energy. Patient satisfaction is significantly higher when their skin is treated with high fluences, but not when patients' skin is treated with high densities. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17457835     DOI: 10.1002/lsm.20484

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  8 in total

Review 1.  Nonablative Fractional Laser Resurfacing in Skin of Color: Evidence-based Review.

Authors:  Shivani B Kaushik; Andrew F Alexis
Journal:  J Clin Aesthet Dermatol       Date:  2017-06-01

2.  Latest laser and light-based advances for ethnic skin rejuvenation.

Authors:  Mohamed Lotfy Elsaie; Heather Woolery Lloyd
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

Review 3.  Fractional photothermolysis--an update.

Authors:  Inja Bogdan Allemann; Joely Kaufman
Journal:  Lasers Med Sci       Date:  2010-01       Impact factor: 3.161

4.  Fractional laser photothermolysis for treatment of facial wrinkles in Asians.

Authors:  Hun Lee; Jin Sook Yoon; Sang Yeul Lee
Journal:  Korean J Ophthalmol       Date:  2009-12-04

5.  Lasers for treatment of melasma and post-inflammatory hyperpigmentation.

Authors:  Pooja Arora; Rashmi Sarkar; Vijay K Garg; Latika Arya
Journal:  J Cutan Aesthet Surg       Date:  2012-04

6.  Histological validity and clinical evidence for use of fractional lasers for acne scars.

Authors:  Kabir Sardana; Vijay K Garg; Pooja Arora; Nita Khurana
Journal:  J Cutan Aesthet Surg       Date:  2012-04

7.  Commentary on the Article, "Efficacy and Safety of 10 600-nm Carbon Dioxide Fractional Laser on Facial Skin with Previous Volume Injections".

Authors:  Niteen V Dhepe
Journal:  J Cutan Aesthet Surg       Date:  2013-01

8.  Treatment of acne scars and wrinkles in asian patients using carbon-dioxide fractional laser resurfacing: its effects on skin biophysical profiles.

Authors:  Young Ji Hwang; Yu Na Lee; Yang Won Lee; Yong Beom Choe; Kyu Joong Ahn
Journal:  Ann Dermatol       Date:  2013-11-30       Impact factor: 1.444

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.